OLŠOVSKÝ, Jindřich. Pioglitazon a kardiovaskulární komplikace (Pioglitazone and cardiovascular complications). Medicína po promoci. Praha: Medical tribune CZ, 2012, vol. 13, "speciální vydání, říjen 2012", p. 6-10. ISSN 1212-9445.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pioglitazon a kardiovaskulární komplikace
Name (in English) Pioglitazone and cardiovascular complications
Authors OLŠOVSKÝ, Jindřich (203 Czech Republic, guarantor, belonging to the institution).
Edition Medicína po promoci, Praha, Medical tribune CZ, 2012, 1212-9445.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30202 Endocrinology and metabolism
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/12:00063741
Organization unit Faculty of Medicine
Keywords (in Czech) diabetes mellitus 2. typu; pioglitazon; kardiovaskulární riziko; studie PROactive
Keywords in English type 2 diabetes mellitus; pioglitazon; cardiovascular risk; trial PROactive
Tags Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 29. 3. 2013 13:55.
Abstract
Autor se zabývá problematikou možných mechanizmů kardiovaskulární protektivity pioglitaazonu u pacientů s diabetem mellitem 2. typu.
Abstract (in English)
Autor discuss mechanism in cardiovascular protective effect of pioglitazon in patients with diabetes mellitus, type 2.
PrintDisplayed: 14. 8. 2022 09:32